Aim higher


Development of a technology platform for the discovery of new industrial biocatalysts from marine bacterial diversity.

Development of a new platform technology for efficient, fast and cost-effective antibody generation.

Alpha galactosidase for the Industry

Development of the next-stage production platform for industrial enzymes

Green indoor growth factory for production of high value compounds through GMO plants.

Development of a Bispecific therapeutic antibody for the treatment of metastatic breast cancer

Medicines with strongly enhanced in vivo stability, optimal receptor interaction, and early indication of clinical success.

Dual Affinity Protein (DAP) technology for single-use affinity purification of antibodies

Integrated Bioprocess Development Solutions for Shaken Cultures